| 3D‐bioprinted mini‐brain: a glioblastoma model to study cellular interactions and therapeutics MA Heinrich, R Bansal, T Lammers, YS Zhang, R Michel Schiffelers, ... Advanced materials 31 (14), 1806590, 2019 | 244 | 2019 |
| Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter V Chaudhuri, R Tayal, B Nayak, SK Acharya, SK Panda Gastroenterology 127 (5), 1356-1371, 2004 | 225 | 2004 |
| Therapeutic targeting of hepatic macrophages for the treatment of liver diseases D van der Heide, R Weiskirchen, R Bansal Frontiers in immunology 10, 494110, 2019 | 199 | 2019 |
| Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery J Schnittert, R Bansal, G Storm, J Prakash Advanced drug delivery reviews 129, 37-53, 2018 | 174 | 2018 |
| Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer K Binnemars‐Postma, R Bansal, G Storm, J Prakash The FASEB Journal 32 (2), 969-978, 2018 | 169 | 2018 |
| Drug targeting to myofibroblasts: Implications for fibrosis and cancer S Yazdani, R Bansal, J Prakash Advanced drug delivery reviews 121, 101-116, 2017 | 160 | 2017 |
| Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice R Bansal, J Prakash, E Post, L Beljaars, D Schuppan, K Poelstra Hepatology 54 (2), 586-596, 2011 | 125 | 2011 |
| Targeting pancreatic stellate cells in cancer J Schnittert, R Bansal, J Prakash Trends in cancer 5 (2), 128-142, 2019 | 124 | 2019 |
| The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis R Bansal, J Van Baarlen, G Storm, J Prakash Scientific reports 5 (1), 18272, 2015 | 108 | 2015 |
| Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles Q Hu, CJ Rijcken, R Bansal, WE Hennink, G Storm, J Prakash Biomaterials 53, 370-378, 2015 | 106 | 2015 |
| Clinical advancements in the targeted therapies against liver fibrosis R Bansal, B Nagórniewicz, J Prakash Mediators of inflammation 2016 (1), 7629724, 2016 | 105 | 2016 |
| Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo DF Mardhian, G Storm, R Bansal, J Prakash Journal of controlled release 290, 1-10, 2018 | 102 | 2018 |
| ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer PR Kuninty, R Bansal, SWL De Geus, DF Mardhian, J Schnittert, ... Science advances 5 (9), eaax2770, 2019 | 101 | 2019 |
| Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis F Poosti, R Bansal, S Yazdani, J Prakash, E Post, P Klok, J van den Born, ... The FASEB Journal 29 (3), 1029-1042, 2015 | 100 | 2015 |
| Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12 BÖ Akcora, G Storm, R Bansal Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (3), 804-818, 2018 | 99 | 2018 |
| Bioengineered 3D models to recapitulate tissue fibrosis M Sacchi, R Bansal, J Rouwkema Trends in biotechnology 38 (6), 623-636, 2020 | 75 | 2020 |
| Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases R Bansal, S Nakagawa, S Yazdani, J Van Baarlen, A Venkatesh, AP Koh, ... Experimental & molecular medicine 49 (11), e396-e396, 2017 | 72 | 2017 |
| Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis R Bansal, J Prakash, M Ruijter, L Beljaars, K Poelstra Molecular pharmaceutics 8 (5), 1899-1909, 2011 | 72 | 2011 |
| Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth R Bansal, T Tomar, A Östman, K Poelstra, J Prakash Molecular cancer therapeutics 11 (11), 2419-2428, 2012 | 64 | 2012 |
| Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model B Öztürk Akcora, G Storm, J Prakash, R Bansal Scientific reports 7 (1), 44545, 2017 | 59 | 2017 |
